Wall Street Breakfast Huawei preps AI chip to challenge Nvidia: report
Apr 28, 2025
Huawei is gearing up to test its new AI chip, aiming to compete with Nvidia. Merck KGaA is making headlines with a $3.9 billion acquisition of SpringWorks, boosting its cancer treatment portfolio. CrowdStrike introduces innovative AI agents to enhance cybersecurity. The conversation also dives into market trends, including tariff impacts and significant stock movers. Exciting insights wrap up the discussion on AI advancements with potential implications for the tech industry.
AI Snips
Chapters
Transcript
Episode notes
Huawei's AI Chip Challenge
- Huawei plans to test its advanced Ascend 910D AI chip as soon as next month.
- The chip aims to surpass NVIDIA's popular H100 from 2022 in power and performance.
Merck's Big Biotech Acquisition
- Merck KGAA is acquiring SpringWorks Therapeutics for about $3.9 billion to expand its cancer treatment business.
- This deal is expected to add revenue immediately and boost long-term growth.
CrowdStrike's Autonomous AI Security
- CrowdStrike's Charlotte AI integrates automation with human expertise for faster cyber threat response.
- Its AI platform now autonomously reasons and acts without needing human prompts.